Alumis ALMS
NASDAQ ALMS
$23.96 +0.93 (+4.04%)
At close: Aug 25, 2026 · 4:00 PM EDT

Alumis (ALMS) Consolidated Net Income (2023 - 2026)

Alumis (ALMS) posted quarterly Consolidated Net Income of -$92.9 million for Q4 2025, down 181.75% year-over-year from $113.6 million in Q4 2024, and up 16.13% quarter-over-quarter from -$110.8 million in Q3 2025.

Alumis (ALMS) Consolidated Net Income (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Consolidated Net Income for 3 consecutive years, with -$92.9 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Consolidated Net Income fell 181.75% year-over-year to -$92.9 million; the TTM figure through Dec 2025 stood at -$250.9 million (down 8.38% YoY), while the FY2025 annual figure was -$243.3 million, down 4.66% from the prior year.
  • Consolidated Net Income improved to -$92.9 million in Q4 2025 per ALMS's latest filing, from -$110.8 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $59.3 million in Q2 2025 and bottomed at -$110.8 million in Q3 2025.
  • Historically, Consolidated Net Income has averaged -$55.0 million across 3 years, with a median of -$48.9 million in 2024.
  • On a YoY basis, Consolidated Net Income climbed as much as 204.98% in 2025 and fell as far as 181.75% in 2025.
  • Alumis' Consolidated Net Income stood at -$41.3 million in 2023, then climbed by 20.16% to -$33.0 million in 2024, then sank by 181.75% to -$92.9 million in 2025.
  • Business Quant data shows ALMS's Consolidated Net Income at -$92.9 million in Q4 2025, -$110.8 million in Q3 2025, and $59.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 140.32 Bn 132.47 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.35 Bn 58.16 Bn 1.37 Bn 482.00 Mn
4 Moderna 63.15 Bn 58.01 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.96 Bn 36.86 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 164.49 Mn
7 Royalty Pharma 27.67 Bn 26.83 Bn - 81.49 Mn
8 BioNTech SE 27.52 Bn 9.13 Bn 668.28 Mn -174.37 Mn
9 Insmed 26.98 Bn 25.82 Bn 358.27 Mn -13.27 Mn
10 Alumis 3.06 Bn 2.56 Bn - -142.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.18 Mn
Dec 31, 2025 -92.89 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 -106.62 Mn
Dec 31, 2024 -32.97 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -48.94 Mn
Dec 31, 2023 -41.30 Mn
Sep 30, 2023 -44.56 Mn
Jun 30, 2023 -36.71 Mn